Home › Funds › C WorldWide Group Holding A/S › NVCR
C WorldWide Group Holding A/S position in NVCR
NOVOCURE LTD · Health Care
C WorldWide Group Holding A/S reported holding 971,784 shares of NVCR (NOVOCURE LTD) in its Q3 2026 13F filing — a position valued at US$15.5M, representing 0.39% of its reported portfolio and ranking #41 among its reported holdings. C WorldWide Group Holding A/S has disclosed NVCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How C WorldWide Group Holding A/S's NVCR position evolved
C WorldWide Group Holding A/S first disclosed a stake in NVCR in Q3 2023 at 221,784 shares (US$3.6M). The position peaked in Q4 2024 at 621,784 shares, worth US$18.5M. Across 13 filings, C WorldWide Group Holding A/S increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 971,784 shares valued at US$15.5M. Notable position changes include a 135% increase in Q4 2023 (shares rose 5% over the following quarter), a 56% increase in Q3 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 221.78K | $3.58M | New |
| Q4 2023 | 521.78K | $7.79M | Add |
| Q1 2024 | 521.78K | $8.15M | Hold |
| Q2 2024 | 521.78K | $8.94M | Hold |
| Q3 2024 | 521.78K | $8.15M | Hold |
| Q4 2024 | 621.78K | $18.53M | Add |
| Q1 2025 | 621.78K | $11.08M | Hold |
| Q2 2025 | 621.78K | $11.07M | Hold |
| Q3 2025 | 971.78K | $12.55M | Add |
| Q4 2025 | 971.78K | $12.56M | Hold |
| Q1 2026 | 971.78K | $10.59M | Hold |
| Q2 2026 | 971.78K | $14.72M | Hold |
| Q3 2026 | 971.78K | $15.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVCR and 13F data
NVCR (NOVOCURE LTD) is a Health Care company. 28 other funds we track also report a position in NVCR — the largest reported positions include Soleus Capital Management, L.P. (US$150.2M), Palo Alto Investors LP (US$19.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCR
- Soleus Capital Management, L.P. 9.91M sh · $150.19M · Q2 2026
- Palo Alto Investors LP 1.28M sh · $19.40M · Q2 2026
More on C WorldWide Group Holding A/S
FAQ
How long has C WorldWide Group Holding A/S held NVCR?
C WorldWide Group Holding A/S has disclosed NVCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is C WorldWide Group Holding A/S's current position in NVCR?
As of Q3 2026, C WorldWide Group Holding A/S holds 971.78K shares of NVCR (NOVOCURE LTD), valued at $15.50M, representing 0.39% of its reported portfolio and ranking #41.
Has C WorldWide Group Holding A/S been buying or selling NVCR?
In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in NVCR. The position peaked in Q4 2024 at 621.78K shares.
Which other funds hold NVCR?
Other major institutional holders of NVCR include Soleus Capital Management, L.P., Palo Alto Investors LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.